🟢 Immunitybio is trading 4.17% up today with no clear company-specific explanation

Immunitybio is trading at $8.24, up 4.17%, with no clear company-specific announcement explaining the September 14, 2026 gain.

• Immunitybio is appearing at the H.C. Wainwright Global Investment Conference from September 14–16; its World Conference on Lung Cancer participation runs through September 15.
• The broader market is lower, so the move does not clearly align with overall index sentiment.
• Recent attention has focused on Anktiva’s patent application and upcoming oncology events, but available coverage does not establish direct causation.